Drug warning: Epilepsy drug Potiga linked to skin and eye abnormalities (Video)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    Hartford Examiner (CT), April 27, 2013 Hartford Health Examiner, 2pp
  • Additional Information
    • Abstract:
      On April 26, 2013, the U.S. Food and Drug Administration (FDA) issued a safety alert regarding the anti-seizure medication Potiga (ezogabine). Potiga is used to treat partial-onset seizures in adults with epilepsy. Epilepsy is a brain disorder that causes recurring seizures. Approximately 60,000 people in Connecticut have epilepsy. One out of every ten people will experience a seizure at some point in their lives...